Facts and figures

The new
Research & Production Facility

  • Established in 1997, Valenta Pharm is a Russian innovative pharmaceutical company involved in development, production, and market launch of high-quality prescription and OTC medicines
  • Over the last 20 years, Valenta Pharm has successfully developed and launched a number of medicinal products for such therapeutic areas as immunology, virology and antibacterial therapy, psychoneurology, gastroenterology, urology, etc.
  • A balanced company portfolio comprises more than 100 medicines represented by both innovative pharma products and branded generics. The range of medicinal products includes such well-known brands as Ingavirin®, Grammidin®, Trimedat, Teraligen, Phenazepam, Pantocalcin®, Aminazin.
  • More than 50% of medicines produced by Valenta Pharm are on the List of Vital and Essential Drugs
  • Valenta Pharm invests heavily in scientific research and portfolio development, as well as medical projects and health-related innovations
  • The Company currently produces over 100 million finished pharmaceutical products per annum within the major therapeutic categories of social importance
  • Valenta Pharm is a continuously developing company taking the lead among Russian pharmaceutical companies.
  • Business geography of Valenta Pharm covers 57 cities throughout of Russia, as well as Belarus, Kyrgyzstan, Azerbaijan, Armenia, and Uzbekistan. Its representation – Valenta Asia – operates in Kazakhstan